Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study.

Ori BarzilaiAnne L VersteegArjun SahgalLaurence D RhinesMark H BilskyDaniel M SciubbaJames M SchusterMichael H WeberPeter Pal VargaStefano BorianiChetan BettegowdaMichael G FehlingsYoshiya YamadaMichelle J ClarkePaul M ArnoldZiya L GokaslanCharles G FisherIlya Laufernull The Ao Spine Knowledge Forum Tumor

Published in: Cancer (2018)

The treatment of oligometastatic disease appears to offer a significant survival advantage compared with polymetastatic disease, regardless of treatment choice. HRQOL measures were found to improve in both groups, demonstrating a palliative benefit for all treated patients.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
spinal cord
palliative care
prognostic factors
clinical trial
spinal cord injury
free survival